Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Kestra Medical Technologies (KMTS) Shares Outstanding (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Shares Outstanding for 3 consecutive years, with $58.3 million as the latest value for Q1 2026.

  • Quarterly Shares Outstanding rose 193.07% to $58.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $58.3 million through Jan 2026, up 193.07% year-over-year, with the annual reading at $51.3 million for FY2025, 157.91% up from the prior year.
  • Shares Outstanding for Q1 2026 was $58.3 million at Kestra Medical Technologies, up from $51.4 million in the prior quarter.
  • The five-year high for Shares Outstanding was $58.3 million in Q1 2026, with the low at $105808.0 in Q1 2024.
  • Average Shares Outstanding over 3 years is $32.5 million, with a median of $19.9 million recorded in 2024.
  • Peak annual rise in Shares Outstanding hit 18716.42% in 2025, while the deepest fall reached 157.91% in 2025.
  • Over 3 years, Shares Outstanding stood at $19.9 million in 2024, then soared by 158.42% to $51.4 million in 2025, then rose by 13.41% to $58.3 million in 2026.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $58.3 million, $51.4 million, and $51.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.